Sources | Names Used |
---|---|
CTRPv2 | selumetinib:PLX-4032 (8:1 mol/mol) |
PharmacoGx | selumetinib:PLX-4032 (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NLRP14 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | TFDP2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | TNRC6A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | GABPA | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | CEP164 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | GPAT3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | KCTD19 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | SH3YL1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
mRNA | USP7 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | CTD-2313N18.7 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |